TRADITIONAL TESTS AND RECENT DIAGNOSTIC MODALITIES FOR TUBERCULOSIS WITH EMPHASIS TO MOLECULAR DETECTION TECHNIQUES, DRUG SENSITIVITY ASSESMENT IN INDIAN PERSPECTIVE
5. ADVANTAGES OF MGIT
ā¢ all type of specimens
ā¢ continuously monitored
ā¢ positive signals over 10-12 days
ā¢ non-radiometeric
ā¢ cheaper than BACTEC
6. DST using rapid culture method
MODS
ā¢ microscopic-observation drug-susceptibility assay
ā¢ antituberculous drug containing Middle brook
7H9 broth
ā¢ growth (cord formation) detected using inverted
light microscope
ā¢ time to detection- 7 days
ā¢ sensitivity 95% & specificity 100%
7. IFN-Ī³ release assays
ā¢ in vitro assays
ā¢ whole blood incubated with TB antigens
ā¢ measures interferon (IFN-Ī³) released by
sensitized T cells
ā¢ measures immune reactivity to M.tb
8.
9. QuantiFERON TB Gold
ā¢ combines IFN-Ī³ release
technology with the
diagnostic power of
synthetic TB-specific
peptides (ESAT-6 and
CFP-10) to provide the
best available method
of diagnosing TB
infection
ā¢ FDA-approved for the
detection of LTBI, 2001.
10. Analysis of IGRA report
Positive IGRA
ā¢ person has been infected with TB bacteria.
additional tests are needed to determine if
the person has latent TB infection or TB
disease
Negative IGRA:
ā¢ latent TB infection or TB disease is not likely
11. MOLECULAR METHODS
ā¢ uncultivable or difficult to culture
ā¢ HIV infected patients
ā¢ rapid result
ā¢ quantitative information (viral load)
ā¢ susceptibility testing (drug resistance) without
culture
12. ā¢ may not differentiate active infection as DNA
from a dead organism during antibiotic
treatment can be detected and amplified by
PCR
ā¢ High cost
13. Nucleic acid amplification tests
ā¢ amplify M. tuberculosis-specific nucleic acid
sequences using a nucleic acid probe
ā¢ sensitivity at least 80% in most studies
ā¢ Require 10 bacilli/ml of given sample
ā¢ specificity 98% to 99%.
14. Molecular methods used in NAAT
For amplification
ā¢ Polymerase chain reaction
ā¢ Transcription mediated amplification
ā¢ Loop mediated isothermal amplification
ā¢ Ligase chain reaction
ā¢ Real time PCR
For detection:
ā¢ Electrophoresis
ā¢ Line probe assay
ā¢ Real time detection
15. Xpert MTB/RIF
ā¢ detects M. tuberculosis & rifampicin
resistance conferring mutations
ā¢ unprecedented sensitivity-smear negative,
culture positive specimens
ā¢ provides results directly from the sputum
within 100 minutes
ā¢ Endorsed by WHO since 2011
16.
17. Xpert MTB/RIF from different samples
SAMPLE SENSITIVITY SPECIFICITY
Sputum 88% 99%
Lymph node aspirate 84.9% 92.5%
CSF 79.5% 98.6%
Pleural fluid 43.7% 98.1%
Gastric lavage/aspirate 83.8% 98.8%
Source: WHO policy update for Xpert MTB/RIF(2013)
18. Line probe assays
ā¢ PCR/hybridization
technique to identify
Mycobacterium
Tuberculosis
ā¢ identify drug-resistant
strains by detecting the
most common single
nucleotide
polymorphorisms
associated with
resistance
20. ā¢ In-house PCR tests are widely used in the
developing countries
ā¢ The line probe assays (LPA) are suitable only
for national or regional level laboratories
because of its complexity and bio safety
requirements
21. Molecular DST- candidates?
ā¢ Patients suspected or at high risk of having drug-
resistant TB
ā¢ very ill patients
ā¢ HIV infected patients
ā¢ who do not get better while taking standard first-
line therapy
22. Lateral flow urine lipoarabinomannan
(LF-LAM)assay
ā¢ From urine of active TB patients
ā¢ Endorsed by WHO in 2015
ā¢ Only for HIV patients- seriously ill/ low CD4
count